Oxybutynin Chloride
Product Images NDC 10135-640

5 FDA label images from Marlex Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10135-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Structural Formula (Oxybutynin Chloride Tablets 01)

The Structural Formula (Oxybutynin Chloride Tablets 01)
Chemical structure of Oxybutynin Chloride, showing its molecular arrangement with labeled bonds and atoms corresponding to the compound.*
FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers. (Oxybutynin Chloride Tablets 02)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers. (Oxybutynin Chloride Tablets 02)
A pharmacokinetic line graph illustrating mean plasma concentrations of oxybutynin (5 mg TID) over a 24-hour period. The x-axis represents time in hours, and the y-axis shows mean plasma oxybutynin concentration in ng/mL, with data points and error bars indicating variability at each time point.*
FDA Label Image

Figure 2. Mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 To 15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybutynin Chloride Tablets 03)

Figure 2. Mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 To 15 Years Of Age. – Plot Represents All Available Data Normalized To The Equivalent Of Oxybutynin Chloride 5 mg Bid Or Tid At Steady State (Oxybutynin Chloride Tablets 03)
A line graph depicting the mean plasma concentration of Oxybutynin over time (hours). The y-axis shows mean plasma Oxybutynin concentration in ng/mL, and the x-axis shows time in hours. Data points show a peak concentration near 1 hour followed by a decline to near baseline by 12 hours, with error bars indicating variability.*
FDA Label Image

Ndc 10135-0640-01marlexpharmaceuticals, Inc.oxybutyninchloride Tablets, Usp5 mgrx Only 100 Tablets (Oxybutynin Chloride Tablets 04)

Ndc 10135-0640-01marlexpharmaceuticals, Inc.oxybutyninchloride Tablets, Usp5 mgrx Only 100 Tablets (Oxybutynin Chloride Tablets 04)
Label of Oxybutynin Chloride Tablets USP 5 mg from Marlex Pharmaceuticals Inc. The label states 100 tablets per container. It includes dosage information for adults and pediatric patients, storage instructions, and a warning to keep out of reach of children. A barcode and NDC 10135-0640-01 are also visible.*
FDA Label Image

Oxybutynin Chloride Tablets 05

Oxybutynin Chloride Tablets 05
Label for Oxybutynin Chloride Tablets, USP 5 mg by Marlex Pharmaceuticals, Inc. The label shows the product name, strength, quantity of 1000 tablets, and a barcode. It also includes dosage instructions for adults and pediatric patients, storage conditions, a warning to keep out of reach of children, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.